1 Division of Pulmonary, Allergy, and Critical Care Medicine, and.
2 University of Alabama at Birmingham Lung Imaging Core, University of Alabama at Birmingham, Birmingham, Alabama.
Ann Am Thorac Soc. 2018 Mar;15(3):281-289. doi: 10.1513/AnnalsATS.201705-377FR.
Lung imaging is increasingly being used to diagnose, quantify, and phenotype chronic obstructive pulmonary disease (COPD). Although spirometry is the gold standard for the diagnosis of COPD and for severity staging, the role of computed tomography (CT) imaging has expanded in both clinical practice and research. COPD is a heterogeneous disease with considerable variability in clinical features, radiographic disease, progression, and outcomes. Recent studies have examined the utility of CT imaging in enhancing diagnostic certainty, improving phenotyping, predicting disease progression and prognostication, selecting patients for intervention, and also in furthering our understanding of the complex pathophysiology of this disease. Multiple CT metrics show promise for use as imaging biomarkers in COPD.
肺部成像越来越多地用于诊断、定量和表型慢性阻塞性肺疾病(COPD)。虽然肺活量测定法是 COPD 诊断和严重程度分期的金标准,但计算机断层扫描(CT)成像在临床实践和研究中的作用已经扩大。COPD 是一种异质性疾病,在临床特征、放射疾病、进展和结局方面存在很大差异。最近的研究检查了 CT 成像在提高诊断确定性、改善表型、预测疾病进展和预后、选择干预患者方面的效用,也有助于我们进一步了解这种疾病的复杂病理生理学。多种 CT 指标有望作为 COPD 的成像生物标志物使用。